NSF and NIH grants will allow Renerva to develop its second product and expand the indication for use of its revolutionary gel for healing injured nerves

Groundbreaking injectable gel helps injured peripheral nerves repair and regenerate

Renerva, LLC, is a rapidly-growing and innovative medical device company with a focus to develop and commercialize implantable technologies to improve the outcome of peripheral nerve repair procedures.

Episode #175 - Dr. Lorenzo Soletti is the Co-Founder and CEO of Renerva, LLC. Dr. Bryan Brown is also the Co-Founder of Renerva, as well as an Assistant Professor in the Department of Bioengineering with a secondary appointment in the Department of Obstetrics, Gynecology, and Reproductive Sciences at the University of Pittsburgh.

Renerva’s main focus is to develop and commercialize implantable technologies to improve the outcome of peripheral nerve repair procedures. The company is committed to developing the next generation of surgical solutions to improve peripheral nerve repair, accelerate healing following a nerve injury, and improve nerve function following injury and repair.